126:
22:
223:
202:
401:
384:
as CP-358774 (Moyer et al. Cancer
Research, 1997, 57:4838), renamed OSI-774 when Pfizer was required to divest the compound in order to complete the buyout of Warner lambert/Parke-Davis and subsequently developed by OSI in conjunction with
700:
507:
As of
February 7, 2007, our number of employees decreased to 554, of which 276 primarily are involved in research, development and manufacturing activities and 140 primarily are involved in the commercialization of our
294:
for $ 4.0 billion. The deal was closed on June 9, 2010. The company closed its last facilities in Long Island in May 2013. OSI had specialized in the discovery and development of molecular targeted therapies. Though
629:
As a result of our decision to divest the eye disease business held by our wholly owned subsidiary, (OSI) Eyetech, Inc., the operating results for (OSI) Eyetech are shown as discontinued operations...
1477:
693:
1487:
709:
686:
1492:
1482:
1497:
1191:
1181:
1171:
1161:
1151:
1141:
1131:
1121:
1111:
1507:
576:
520:
Astellas to Buy OSI Pharma for $ 4 Billion, Michael J. de la Merced, New York Times Deal Book, May 16, 2010, retrieved March 29, 2019
105:
86:
1456:
369:
320:
467:
58:
372:(EGFR) and is the only EGFR inhibitor to have demonstrated the ability to improve overall survival in advanced non-small cell
1324:
43:
36:
65:
863:
1082:
519:
1439:
893:
72:
888:
641:
581:
531:
Companies that left Long Island or downsized over the years, Newsday, February 21, 2017, retrieved March 29, 2019.
1062:
1032:
1017:
945:
930:
868:
813:
327:, meant to provide control over this product and diversify the company, was unsuccessful, ending in divestiture.
54:
1502:
1329:
1037:
778:
1394:
530:
614:
492:
1244:
965:
955:
950:
808:
748:
339:
32:
1349:
1319:
1269:
1224:
1072:
763:
586:
545:
263:
440:
335:
1424:
1229:
1047:
1012:
858:
838:
267:
330:
In mid-2007, OSI's revenues were based primarily on proceeds from
Tarceva sales (which are shared with
308:
668:
1384:
1359:
1309:
1304:
1284:
1234:
1167:
1157:
1027:
1002:
910:
905:
873:
803:
773:
590:
287:
206:
1409:
1374:
1289:
1274:
997:
992:
733:
723:
672:
1334:
1147:
1117:
1067:
833:
818:
188:
164:
79:
678:
1314:
1279:
768:
377:
311:. OSI had also made a foray into the ophthalmology market through a marketing agreement with
1042:
980:
960:
915:
900:
843:
406:
365:
125:
1389:
1299:
1294:
935:
883:
853:
300:
291:
250:
1219:
925:
279:
245:
146:
1471:
1399:
1197:
1099:
1007:
1177:
1369:
1052:
920:
444:
373:
227:
21:
1429:
1057:
788:
414:
396:
316:
275:
215:
136:
1379:
1249:
1022:
987:
848:
823:
386:
361:
357:
351:
331:
602:
OSI has a single marketed product backed by a mostly early-stage pipeline.
1259:
1254:
1137:
1127:
798:
417:(OSI-906), an inhibitor of IGF-1R in clinical trials for cancer treatment
296:
271:
645:
1414:
1264:
1187:
1107:
1077:
975:
940:
878:
793:
753:
738:
324:
304:
1419:
1354:
1344:
1239:
970:
783:
728:
381:
364:
and, as of 2007, only marketed product. Tarceva is a small molecule
312:
1434:
1404:
1339:
828:
758:
743:
283:
299:
was the top priority for OSI, research and development targeting
1214:
682:
549:
15:
282:. On Sunday, May 16, 2010 OSI agreed to be acquired by
1478:
Defunct pharmaceutical companies of the United States
1207:
1098:
1091:
716:
244:
234:
213:
196:
184:
170:
160:
152:
142:
132:
307:had been conducted through their U.K. subsidiary
1488:Health care companies based in New York (state)
462:
460:
570:
568:
566:
434:
432:
430:
710:Pharmaceutical companies of the United States
694:
540:
538:
498:. OSI Pharmaceuticals. 2007-02-28. p. 22
8:
1493:Pharmaceutical companies established in 1983
620:. OSI Pharmaceuticals. 2007-02-28. p. 5
582:Genetic Engineering & Biotechnology News
118:
1483:Companies based in Suffolk County, New York
1095:
701:
687:
679:
117:
106:Learn how and when to remove this message
1498:Companies formerly listed on the Nasdaq
426:
675:Web Archives (archived 2002-09-21)
42:Please improve this article by adding
644:. OSI Pharmaceuticals. Archived from
577:"OSI Pharma Needs to Expand Pipeline"
548:. OSI Pharmaceuticals. Archived from
7:
323:; however, acquisition of the firm
988:Pharmaceutical Product Development
468:"OSI Pharmaceuticals - Financials"
338:) and royalty payments related to
14:
342:inhibitor intellectual property.
1457:List of pharmaceutical companies
399:
370:epidermal growth factor receptor
321:Age-related macular degeneration
222:
221:
201:
200:
124:
20:
575:Querida Anderson (2007-06-15).
1:
1508:2010 mergers and acquisitions
864:Institute for OneWorld Health
380:. Tarceva was discovered by
44:secondary or tertiary sources
1083:West Pharmaceutical Services
1524:
889:McNeil Consumer Healthcare
589:p. 14. Archived from
441:"OSI Pharmaceuticals, Inc"
349:
180:Robert A. Ingram, Chairman
1452:
1395:Smith, Kline & French
946:Northwest Biotherapeutics
931:Merrimack Pharmaceuticals
642:"Products & Pipeline"
123:
119:OSI Pharmaceuticals, Inc.
340:dipeptidyl-peptidase IV
262:, Inc. was an American
1320:Leiner Health Products
764:Amneal Pharmaceuticals
587:Mary Ann Liebert, Inc.
264:pharmaceutical company
31:relies excessively on
874:Johnson & Johnson
268:Long Island, New York
178:Michael G. Atieh, CFO
55:"OSI Pharmaceuticals"
1168:Jazz Pharmaceuticals
1158:Horizon Therapeutics
1028:Sarepta Therapeutics
1003:Proteon Therapeutics
998:Procter & Gamble
911:Melinta Therapeutics
804:Bristol Myers Squibb
615:"2006 Annual Report"
493:"2006 Annual Report"
1375:Repros Therapeutics
1290:Forest Laboratories
1275:Cutter Laboratories
993:Prasco Laboratories
734:Acorda Therapeutics
724:Abbott Laboratories
673:Library of Congress
669:OSI Pharmaceuticals
270:with facilities in
260:OSI Pharmaceuticals
236:Number of employees
120:
1335:Miles Laboratories
1325:Martek Biosciences
1148:Endo International
1068:Ventria Bioscience
834:Danco Laboratories
266:formerly based in
189:Biopharmaceuticals
176:Colin Goddard, CEO
165:Melville, New York
1465:
1464:
1448:
1447:
1280:DNAPrint Genomics
769:Avax Technologies
378:pancreatic cancer
336:Hoffmann–La Roche
309:Prosidion Limited
257:
256:
226:$ -582.2 Million
116:
115:
108:
90:
1515:
1096:
1043:Tec Laboratories
916:Melior Discovery
901:Kinetic Concepts
844:Galena Biopharma
703:
696:
689:
680:
657:
656:
654:
653:
638:
632:
631:
626:
625:
619:
611:
605:
604:
599:
598:
572:
561:
560:
558:
557:
542:
533:
528:
522:
517:
511:
510:
504:
503:
497:
489:
483:
482:
480:
479:
464:
455:
454:
452:
451:
436:
409:
407:Companies portal
404:
403:
402:
225:
224:
204:
203:
128:
121:
111:
104:
100:
97:
91:
89:
48:
24:
16:
1523:
1522:
1518:
1517:
1516:
1514:
1513:
1512:
1503:Astellas Pharma
1468:
1467:
1466:
1461:
1444:
1390:Schering-Plough
1300:ImClone Systems
1203:
1087:
936:Myriad Genetics
926:Merck & Co.
884:Janssen Biotech
854:Gilead Sciences
712:
707:
665:
660:
651:
649:
640:
639:
635:
623:
621:
617:
613:
612:
608:
596:
594:
574:
573:
564:
555:
553:
544:
543:
536:
529:
525:
518:
514:
501:
499:
495:
491:
490:
486:
477:
475:
466:
465:
458:
449:
447:
438:
437:
428:
424:
405:
400:
398:
395:
354:
348:
301:type 2 diabetes
292:Astellas Pharma
251:Astellas Pharma
237:
218:
205:$ 375.7 Million
192:Biotherapeutics
191:
179:
177:
173:
112:
101:
95:
92:
49:
47:
41:
37:primary sources
25:
12:
11:
5:
1521:
1519:
1511:
1510:
1505:
1500:
1495:
1490:
1485:
1480:
1470:
1469:
1463:
1462:
1460:
1459:
1453:
1450:
1449:
1446:
1445:
1443:
1442:
1437:
1432:
1427:
1422:
1417:
1412:
1407:
1402:
1397:
1392:
1387:
1382:
1377:
1372:
1367:
1362:
1357:
1352:
1347:
1342:
1337:
1332:
1327:
1322:
1317:
1312:
1307:
1302:
1297:
1292:
1287:
1282:
1277:
1272:
1267:
1262:
1257:
1252:
1247:
1242:
1237:
1232:
1227:
1222:
1220:Allergan, Inc.
1217:
1211:
1209:
1205:
1204:
1202:
1201:
1200:(Canada, 2010)
1195:
1185:
1175:
1165:
1155:
1145:
1135:
1125:
1115:
1104:
1102:
1093:
1089:
1088:
1086:
1085:
1080:
1075:
1070:
1065:
1060:
1055:
1050:
1045:
1040:
1035:
1030:
1025:
1020:
1015:
1010:
1005:
1000:
995:
990:
985:
984:
983:
978:
968:
963:
958:
953:
951:Norwich Pharma
948:
943:
938:
933:
928:
923:
918:
913:
908:
903:
898:
897:
896:
891:
886:
881:
871:
866:
861:
856:
851:
846:
841:
836:
831:
826:
821:
816:
811:
806:
801:
796:
791:
786:
781:
776:
771:
766:
761:
756:
751:
746:
741:
736:
731:
726:
720:
718:
714:
713:
708:
706:
705:
698:
691:
683:
677:
676:
664:
663:External links
661:
659:
658:
633:
606:
562:
534:
523:
512:
484:
456:
425:
423:
420:
419:
418:
411:
410:
394:
391:
347:
344:
315:over Macugen (
280:United Kingdom
255:
254:
253:(2010-present)
248:
242:
241:
238:
235:
232:
231:
219:
214:
211:
210:
198:
194:
193:
186:
182:
181:
174:
171:
168:
167:
162:
158:
157:
154:
150:
149:
147:Pharmaceutical
144:
140:
139:
134:
130:
129:
114:
113:
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
1520:
1509:
1506:
1504:
1501:
1499:
1496:
1494:
1491:
1489:
1486:
1484:
1481:
1479:
1476:
1475:
1473:
1458:
1455:
1454:
1451:
1441:
1438:
1436:
1433:
1431:
1428:
1426:
1423:
1421:
1418:
1416:
1413:
1411:
1408:
1406:
1403:
1401:
1400:Sterling Drug
1398:
1396:
1393:
1391:
1388:
1386:
1383:
1381:
1378:
1376:
1373:
1371:
1368:
1366:
1363:
1361:
1358:
1356:
1353:
1351:
1348:
1346:
1343:
1341:
1338:
1336:
1333:
1331:
1328:
1326:
1323:
1321:
1318:
1316:
1313:
1311:
1308:
1306:
1303:
1301:
1298:
1296:
1293:
1291:
1288:
1286:
1283:
1281:
1278:
1276:
1273:
1271:
1268:
1266:
1263:
1261:
1258:
1256:
1253:
1251:
1248:
1246:
1243:
1241:
1238:
1236:
1233:
1231:
1228:
1226:
1223:
1221:
1218:
1216:
1213:
1212:
1210:
1206:
1199:
1198:Bausch Health
1196:
1193:
1189:
1186:
1183:
1179:
1176:
1173:
1169:
1166:
1163:
1159:
1156:
1153:
1149:
1146:
1143:
1139:
1136:
1133:
1129:
1126:
1123:
1119:
1116:
1113:
1109:
1106:
1105:
1103:
1101:
1100:Tax inversion
1097:
1094:
1090:
1084:
1081:
1079:
1076:
1074:
1071:
1069:
1066:
1064:
1061:
1059:
1056:
1054:
1051:
1049:
1046:
1044:
1041:
1039:
1036:
1034:
1031:
1029:
1026:
1024:
1021:
1019:
1016:
1014:
1011:
1009:
1008:Purdue Pharma
1006:
1004:
1001:
999:
996:
994:
991:
989:
986:
982:
979:
977:
974:
973:
972:
969:
967:
964:
962:
959:
957:
954:
952:
949:
947:
944:
942:
939:
937:
934:
932:
929:
927:
924:
922:
919:
917:
914:
912:
909:
907:
904:
902:
899:
895:
892:
890:
887:
885:
882:
880:
877:
876:
875:
872:
870:
867:
865:
862:
860:
857:
855:
852:
850:
847:
845:
842:
840:
837:
835:
832:
830:
827:
825:
822:
820:
817:
815:
812:
810:
807:
805:
802:
800:
797:
795:
792:
790:
787:
785:
782:
780:
777:
775:
772:
770:
767:
765:
762:
760:
757:
755:
752:
750:
747:
745:
742:
740:
737:
735:
732:
730:
727:
725:
722:
721:
719:
715:
711:
704:
699:
697:
692:
690:
685:
684:
681:
674:
670:
667:
666:
662:
648:on 2008-01-30
647:
643:
637:
634:
630:
616:
610:
607:
603:
593:on 2007-08-22
592:
588:
584:
583:
578:
571:
569:
567:
563:
552:on 2008-01-30
551:
547:
541:
539:
535:
532:
527:
524:
521:
516:
513:
509:
494:
488:
485:
474:. EDGAROnline
473:
469:
463:
461:
457:
446:
442:
439:Kristi Park.
435:
433:
431:
427:
421:
416:
413:
412:
408:
397:
392:
390:
388:
383:
379:
376:and advanced
375:
371:
367:
363:
359:
353:
345:
343:
341:
337:
333:
328:
326:
322:
318:
314:
310:
306:
302:
298:
293:
289:
285:
281:
277:
273:
269:
265:
261:
252:
249:
247:
243:
240:554 (2007-02)
239:
233:
229:
220:
217:
212:
208:
199:
195:
190:
187:
183:
175:
169:
166:
163:
159:
155:
151:
148:
145:
141:
138:
135:
131:
127:
122:
110:
107:
99:
88:
85:
81:
78:
74:
71:
67:
64:
60:
57: –
56:
52:
51:Find sources:
45:
39:
38:
34:
29:This article
27:
23:
18:
17:
1364:
1178:Mallinckrodt
1063:Upsher-Smith
894:Ortho-McNeil
650:. Retrieved
646:the original
636:
628:
622:. Retrieved
609:
601:
595:. Retrieved
591:the original
580:
554:. Retrieved
550:the original
546:"Who We Are"
526:
515:
506:
500:. Retrieved
487:
476:. Retrieved
471:
448:. Retrieved
360:) was OSI's
355:
329:
259:
258:
161:Headquarters
133:Company type
102:
93:
83:
76:
69:
62:
50:
30:
1370:Parke-Davis
1053:Trevena Inc
921:Mentholatum
729:AbbVie Inc.
374:lung cancer
1472:Categories
1430:ViroPharma
1330:Massengill
1058:Ultragenyx
789:Bioverativ
652:2008-01-20
624:2008-01-20
597:2008-01-20
556:2008-01-20
502:2008-01-20
478:2008-01-20
450:2008-01-20
422:References
415:Linsitinib
350:See also:
317:Pegaptanib
276:New Jersey
216:Net income
172:Key people
137:Subsidiary
66:newspapers
33:references
1380:Qualitest
1250:CancerVax
1033:Sheffield
1023:RespireRx
1018:Regeneron
869:Intercept
849:Genentech
839:Eli Lilly
824:CytoSport
814:Ceragenix
508:products.
387:Genentech
366:inhibitor
358:Erlotinib
356:Tarceva (
352:Erlotinib
332:Genentech
96:June 2014
1260:CoTherix
1255:Cephalon
1138:Covidien
1128:Allergan
1118:Alkermes
1038:Spectrum
906:McKesson
799:Biovista
779:BioCryst
472:Hoover's
445:Hoover's
393:See also
362:flagship
297:oncology
290:-listed
286:-based,
278:and the
272:Colorado
185:Products
143:Industry
1415:Trubion
1265:Covance
1245:Bradley
1194:, 2013)
1192:Ireland
1188:Perrigo
1184:, 2013)
1182:Ireland
1174:, 2012)
1172:Ireland
1164:, 2014)
1162:Ireland
1154:, 2014)
1152:Ireland
1144:, 2007)
1142:Ireland
1134:, 2015)
1132:Ireland
1124:, 2011)
1122:Ireland
1114:, 2013)
1112:Ireland
1108:Actavis
1078:Viatris
976:Hospira
966:Ovation
961:Organon
956:NovaBay
941:Moderna
879:Ethicon
809:Century
794:Biovest
754:Alnylam
749:Alexion
739:Advaxis
717:Current
671:at the
368:of the
346:Tarceva
325:Eyetech
305:obesity
197:Revenue
153:Founded
80:scholar
1440:Zonite
1420:Upjohn
1355:Nuvelo
1350:Nereus
1345:Naurex
1270:Cubist
1240:Biolex
1225:Amylin
1092:Former
1073:Vertex
981:Searle
971:Pfizer
784:Biogen
774:Baxter
382:Pfizer
319:) for
313:Pfizer
246:Parent
230:(2006)
209:(2006)
82:
75:
68:
61:
53:
1435:Wyeth
1425:Verus
1405:Tanox
1385:Rib-X
1360:Ortho
1340:Mylan
1295:Genta
1230:ARIAD
1208:Other
1048:Titan
1013:Quark
859:Ionis
829:CytRx
819:Combe
759:Amgen
744:Alcon
618:(PDF)
496:(PDF)
284:Japan
87:JSTOR
73:books
1310:King
1305:ISTA
1285:Epix
1235:Barr
1215:Alza
334:and
303:and
156:1983
59:news
1410:TAP
1365:OSI
288:TSE
228:USD
207:USD
35:to
1474::
1315:KV
627:.
600:.
585:.
579:.
565:^
537:^
505:.
470:.
459:^
443:.
429:^
389:.
274:,
46:.
1190:(
1180:(
1170:(
1160:(
1150:(
1140:(
1130:(
1120:(
1110:(
702:e
695:t
688:v
655:.
559:.
481:.
453:.
109:)
103:(
98:)
94:(
84:·
77:·
70:·
63:·
40:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
